Sanara MedTech Inc. — Director's Dealing 2022

Dec 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2022-12-02

Reporting Person: Bowman Shawn M. (Pres. - Strat. Partnerships)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-02	Common Stock	F	1224	$30.79	Disposed	17326	Direct
2022-12-02	Common Stock	F	1101	$36.86	Disposed	16225	Direct
2022-12-02	Common Stock	F	82	$30.79	Disposed	16143	Direct
2022-12-02	Common Stock	F	260	$22.97	Disposed	15883	Direct
2022-12-02	Common Stock	D	4414	—	Disposed	11469	Direct

Footnotes

F1: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 5,022 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 4,519 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F3: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 334 shares of restricted stock granted to the reporting person on April 27, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F4: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,065 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F5: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated, and forfeited by the reporting person in connection with his resignation as President, Strategic Partnerships, effective December 2, 2022.